Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
The Effect of Weight Losing to Benign Prostate Hyperplasia Patients with Metabolic Syndrome
| LU Yong1*, LI Jin-lian2, WU Yan-lin3, PANG Shu-guang1, HU Su1 and JIANG-Qiang1 | |
| 1Department of Endocrinology, Jinan Central Hospital, Jinan, China | |
| 2Department of Neurology, The Fifth People’s Hospital of Jinan, Jinan, China | |
| 33Department of Urology, Jinan Central Hospital, Jinan, China | |
| Corresponding Author : | LU Yong Department of endocrinology Jinan central hospital Jinan 250013, China E-mail: ly1@medmail.com.cn |
| Received october 02, 2012; Accepted November 26, 2012; Published November 28, 2012 | |
| Citation: Yong L, Jin-Lian L, Yan-Lin W, Shu-Guang P, Su H, et al. (2012) The Effect of Weight Losing to Benign Prostate Hyperplasia Patients with Metabolic Syndrome. J Obes Wt Loss Ther 2:151. doi:10.4172/2165-7904.1000151 | |
| Copyright: © 2012 Yong L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
Abstract
Objective: To explore the effect of weight losing to benign prostate hyperplasia patients with metabolic syndrome.
Methods: We chose 82 benign prostate hyperplasia patients who came for treatment in 2010 and divided them into group A and group B randomly. We measured body weight, height, and calculated body mass index, and we also measured blood pressure, fasting plasma glucose, total triglycerides, high density lipoprotein cholesterol, prostate specific antigen, prostate volume, and international prostate syndrome score. Group A received standard treatment; Group B got extra weight losing direction besides standard treatment. After six months, we compared the abovementioned measurements.
Results: BMI, prostate volume, international prostate syndrome score and total triglycerides in group B are significant lower than group A.
Conclusions On the basis of standard treatment metabolic syndrome patients with benign prostate hyperplasia
can benefit more from weight losing.
